n-(3-pyridyl)-3-phenylsuccinimide has been researched along with maltodextrin in 1 studies
Studies (n-(3-pyridyl)-3-phenylsuccinimide) | Trials (n-(3-pyridyl)-3-phenylsuccinimide) | Recent Studies (post-2010) (n-(3-pyridyl)-3-phenylsuccinimide) | Studies (maltodextrin) | Trials (maltodextrin) | Recent Studies (post-2010) (maltodextrin) |
---|---|---|---|---|---|
18 | 0 | 14 | 1,206 | 202 | 697 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
BĂ©nard, M; Brinkhuizen, C; Carpentier, R; Dubuquoy, L; Galas, L; Lebon, A; Shapman, D; Tardivel, M | 1 |
1 other study(ies) available for n-(3-pyridyl)-3-phenylsuccinimide and maltodextrin
Article | Year |
---|---|
Dipalmitoyl-phosphatidylserine-filled cationic maltodextrin nanoparticles exhibit enhanced efficacy for cell entry and intracellular protein delivery in phagocytic THP-1 cells.
Topics: Humans; Nanoparticles; Phosphatidylserines; THP-1 Cells; Virus Internalization | 2023 |